In:
Eurosurveillance, European Centre for Disease Control and Prevention (ECDC), Vol. 24, No. 50 ( 2019-12-12)
Abstract:
From June to October 2019, 17 patients (six infected, 11 colonised) with an extensively drug-resistant (XDR) Klebsiella pneumoniae strain were notified from four Western Pomerania medical facilities. The XDR K. pneumoniae produced carbapenemases NDM-1 and OXA-48, and was only susceptible to chloramphenicol, tigecycline and cefiderocol. Synergistic activity was observed for the combination of aztreonam plus ceftazidime-avibactam. Genomic analyses showed all isolates belonged to K. pneumoniae sequence type 307. Control measures and further investigations are ongoing.
Type of Medium:
Online Resource
ISSN:
1560-7917
DOI:
10.2807/1560-7917.ES.2019.24.50.1900734
Language:
English
Publisher:
European Centre for Disease Control and Prevention (ECDC)
Publication Date:
2019
detail.hit.zdb_id:
2059112-3
Bookmarklink